All In Biotech

Drug Trial Radar · NCT06052293

Phase 1 Study to Assess Safety and Efficacy of ANG003

A Phase 1 Open-Label, Multicenter Study to Assess the Safety and Efficacy of ANG003 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

57

Actual

Start

Aug 25, 2023

Primary completion

Jul 8, 2024

Study completion Jul 8, 2024

Sponsor

Lead sponsor
Anagram Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 25, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized, parallel, active-treatment Phase 1 study of a single dose of orally administered ANG003 with a test meal in adult subjects with cystic fibrosis-related exocrine pancreatic insufficiency. The study's overall objectives are to evaluate the safety, tolerability and effect of four dose levels of ANG003.

Conditions

  • Exocrine Pancreatic Insufficiency

Interventions

  • ANG003Drug

    To evaluate four possible combinations of lipase, protease and amylase.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse Events (AE), Serious Adverse Events (SAE) and AEs Leading to Study DiscontinuationTime frame: Assessed through study completion, up to 9 days (Day 1 thru Day 9).

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Long Beach Memorial Medical Center

    Long Beach, California

  • National Jewish Health

    Denver, Colorado

  • Norton Children's Research Institute affiliated with University of Louisville School of Medicine

    Louisville, Kentucky

  • Massachusetts General Hospital,

    Boston, Massachusetts

  • Boston Children's Hospital

    Boston, Massachusetts

  • University of Michigan Medical Center

    Ann Arbor, Michigan

  • Harper University Hospital / Wayne State University

    Detroit, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire

  • Albany Medical College

    Albany, New York

  • New York Medical College at Westchester Medical Center

    Valhalla, New York

  • Akron Childrens Hospital

    Akron, Ohio

  • University of Cincinnati

    Cincinnati, Ohio

  • University Hospitals of Cleveland Medical Center

    Cleveland, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • University of Utah

    Salt Lake City, Utah

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.